Patents:
Issued
Weber GF. Peptide sequence that promotes tumor invasion. US Patents 7,807,790 B2
(2010) and 8,969,020 (2015).
Weber GF. Peptide sequence that promotes tumor invasion. European Patent 1 949 109
B1 – Germany, England, France, Sweden (2012).
Mirza M, Shaughnessy E, Weber GF, Hurley JK, Vanpatten KA, Pestano G. Grading,
staging and prognosing cancer using osteopontin-c. European Patent
WO2009052286A1 – Switzerland, Germany, Denmark, Spain, France, Great Britain,
Italy (2015).
Mirza M, Shaughnessy E, Weber GF, Hurley JK, Vanpatten KA, Pestano G. Grading,
staging and prognosing cancer using osteopontin-c. US Patents 9,873,915 (2018) and
10,934,591 B2 (2021).
Pending
Weber GF. A prognostic test for early-stage breast lesions. US Patent Application
62/554,712 and PCT Application WO/2019/051041 (filed 09/2018).
Weber GF. Isolated antibodies and fragments thereof with specificity for Osteopontin-c.
International Patent Application PCT/US2021/035379 (filed 06/2021).
